Chan, Phillip <br/><br/>
Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort.  [electronic resource] 

 -  AIDS research and therapy  01 2020 
 - 1 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1742-6405 
<br/><br/><label>Standard No.: </label>10.1186/s12981-019-0257-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Data Analysis<br/>Drug Substitution--adverse effects<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--adverse effects<br/>HIV-1--drug effects<br/>Heterocyclic Compounds, 3-Ring--adverse effects<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Mental Disorders--etiology<br/>Mood Disorders--etiology<br/>Oxazines--adverse effects<br/>Piperazines--adverse effects<br/>Prospective Studies<br/>Pyridones--adverse effects